Referencia	Autores	Título de artículo
001	Goodman SG, Cohen M, Bigonzi F, Furfinkel EP, Radley DR, Le Iouer V, Fromell GJ, Demers C, Turpie AG, Califf RM, Fox KA, Langer A	Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events.
002	Ellison J, Walker ID, Greer IA	Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy.
003	Cohen M, Antman EM, Gurfinkel E, Turpie AG, Furst J, Bigonzi F, Radley D	Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction
004	Antonelli D, Fares L 2nd, Anene C	Enoxaparin associated with hugh abdominal wall hematomas: a report of two cases.
005	Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E	The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making
006	Quartermain D, Li Y, Jonas S	Enoxaparin, a low molecular weight heparin decreases infarct size and improves sensorimotor function in a rat model of focal cerebral ischemia.
007	Colwell CW Jr, Spiro TE, Trowbridge AA, Stephens JW, Gardiner GA Jr, Ritter MA	Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.
008	Colwell CW Jr, Spiro TE, Trowbridge AA, Morris BA, Kwaan HC, Blaha JD, Comerota AJ, Skoutakis VA	Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group
009	Spiro TE, Johnson GJ, Christie MJ, Lyons RM, MacFarlane DE, Blasier RB, Tremaine MD	Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group.
010	Anonymous	Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study Group.